A randomized, double-blind, controlled trial for effect and safety of Different Concentration Ropivacaine for Costclavicular Space Brachial Plexus Block anesthesia

Clinical Observation on Efficacy and Safety of Costoclavicular Space Brachial Plexus Block with Ropivacaine of Different Concentration: a randomized, double-blind, single-center clinical study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030657

Enrollment

Unknown

Registered

2020-03-08

Start date

2020-05-09

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brachial Plexus Block

Interventions

Experimental group:0.375% ropivacaine 20ml

Control group: 0.5% ropivacaine 20ml

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: the informed consent signed with patients, the forearm and hand surgery of 70 patients was performed at selected time. No gender limitation, ASA I-II, aged 18-65 years old.

Exclusion criteria

Exclusion criteria: no local anaesthetic allergy or injured-limb nerve damage or paresthesia, no abnormal coagulation coagulation, no damage or infection for puncture place, no spirit, language or hearing disorder.

Design outcomes

Primary

Measure	Time frame
the rate of successful blockade 30 min after the with drawal of the needle.;	—

Secondary

Measure	Time frame
onset time;The time to recovery of sensory and motor function after operation;The depth of CCS from the skin surface;	—

Countries

China

Contacts

Public ContactLin Chunshui

Department of Anesthesiology, Nanfang Hospital Affiliated to Southern Medical University

lcsnfyy@126.com+86 13802784698

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026